Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
05 Sep 2024 |
AA01 |
Previous accounting period extended from 31 December 2023 to 31 March 2024
|
|
|
16 May 2024 |
AD01 |
Registered office address changed from C/O Evgen Pharma Suite 24G13 - Block 24 Alderley Park, Congleton Road Nether Alderley SK10 4TG United Kingdom to Theracryf Plc Alderley Park Congleton Road Nether Alderley SK10 4TG on 16 May 2024
|
|
|
16 May 2024 |
AP01 |
Appointment of Dr Huw Jones as a director on 5 April 2024
|
|
|
19 Apr 2024 |
AD01 |
Registered office address changed from 6-7 Citibase, New Barclay House 234 Botley Road Oxford OX2 0HP England to C/O Evgen Pharma Suite 24G13 - Block 24 Alderley Park, Congleton Road Nether Alderley SK10 4TG on 19 April 2024
|
|
|
19 Apr 2024 |
TM01 |
Termination of appointment of Martin Henry Diggle as a director on 5 April 2024
|
|
|
19 Apr 2024 |
TM01 |
Termination of appointment of Michael Moore as a director on 5 April 2024
|
|
|
19 Apr 2024 |
TM01 |
Termination of appointment of Shawn David Manning as a director on 5 April 2024
|
|
|
19 Apr 2024 |
AP01 |
Appointment of Toni Markus Antero Haenninen as a director on 5 April 2024
|
|
|
09 Apr 2024 |
CS01 |
Confirmation statement made on 5 March 2024 with updates
|
|
|
29 Sep 2023 |
AA |
Total exemption full accounts made up to 31 December 2022
|
|
|
18 Sep 2023 |
SH01 |
Statement of capital following an allotment of shares on 17 August 2023
|
|
|
03 May 2023 |
AP01 |
Appointment of Dr Shawn David Manning as a director on 30 April 2023
|
|
|
03 May 2023 |
AP01 |
Appointment of Dr Michael Moore as a director on 30 April 2023
|
|
|
03 May 2023 |
TM02 |
Termination of appointment of Christian Gurth Hoyer Millar as a secretary on 30 April 2023
|
|
|
03 May 2023 |
TM01 |
Termination of appointment of Christian Gurth Hoyer Millar as a director on 30 April 2023
|
|
|
03 May 2023 |
TM01 |
Termination of appointment of Huw Jones as a director on 30 April 2023
|
|
|
21 Apr 2023 |
CS01 |
Confirmation statement made on 5 March 2023 with no updates
|
|
|
22 Dec 2022 |
AD01 |
Registered office address changed from C/O Mercer Lewin 41 Cornmarket Street Oxford OX1 3HA to 6-7 Citibase, New Barclay House 234 Botley Road Oxford OX2 0HP on 22 December 2022
|
|
|
30 Sep 2022 |
AA |
Total exemption full accounts made up to 31 December 2021
|
|
|
15 Mar 2022 |
CS01 |
Confirmation statement made on 5 March 2022 with no updates
|
|
|
28 Apr 2021 |
AA |
Total exemption full accounts made up to 31 December 2020
|
|
|
23 Mar 2021 |
CS01 |
Confirmation statement made on 5 March 2021 with no updates
|
|
|
10 Nov 2020 |
TM01 |
Termination of appointment of Michael Moore as a director on 10 November 2020
|
|
|
26 May 2020 |
SH01 |
Statement of capital following an allotment of shares on 30 April 2019
|
|
|
01 Apr 2020 |
TM01 |
Termination of appointment of Christopher Malcolm Towler as a director on 27 March 2020
|
|